New hope for Tough-to-Treat lung cancer: trial tests drug to boost chemo power
NCT ID NCT07155200
Summary
This study is testing whether adding a new drug called cirtuvivint to standard chemotherapy is safe and more effective for people with small cell lung cancer that has returned after initial treatment. The trial will enroll about 42 adults whose cancer has progressed after prior platinum-based chemotherapy. Researchers hope this combination will help shrink tumors and delay cancer growth better than current options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Washington University School of Medicine
RECRUITINGSt Louis, Missouri, 63110, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.